Global Targeted Therapy for Breast Cancer market growth is projected to reach  US$ 7641 million in 2025 to US$ 14050 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.

Global Targeted Therapy for Breast Cancer Market Trends and Analysis 2025-31

The global Targeted Therapy for Breast Cancer market size is predicted to grow from US$ 7641 million in 2025 to US$ 14050 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031. Breast canceris a disease in which cells in the breast grow out of control. There are different kinds ofbreast cancer. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Targeted Therapy for Breast Cancer Industry Forecast looks at past sales and reviews total world Targeted Therapy for Breast Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Therapy for Breast Cancer sales for 2025 through 2031. With Targeted Therapy for Breast Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Therapy for Breast Cancer industry. This Insight Report provides a comprehensive analysis of the global Targeted Therapy for Breast Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Therapy for Breast Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Targeted Therapy for Breast Cancer market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Therapy for Breast Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Therapy for Breast Cancer. This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Therapy for Breast Cancer market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Brand Drugs &nbsp;&nbsp;&nbsp; Generic Drug Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Retail Pharmacy &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Eli Lilly and Company &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; Merck & Co. &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Merck KGaA &nbsp;&nbsp;&nbsp; Astellas &nbsp;&nbsp;&nbsp; Janssen Biotech &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; Gilead Sciences

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Targeted Therapy for Breast Cancer Market Size (2020-2031) &nbsp;2.1.2 Targeted Therapy for Breast Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Targeted Therapy for Breast Cancer by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Targeted Therapy for Breast Cancer Segment by Type &nbsp;2.2.1 Brand Drugs &nbsp;2.2.2 Generic Drug &nbsp;2.3 Targeted Therapy for Breast Cancer Market Size by Type &nbsp;2.3.1 Targeted Therapy for Breast Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Targeted Therapy for Breast Cancer Market Size Market Share by Type (2020-2025) &nbsp;2.4 Targeted Therapy for Breast Cancer Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Retail Pharmacy &nbsp;2.4.3 Other &nbsp;2.5 Targeted Therapy for Breast Cancer Market Size by Application &nbsp;2.5.1 Targeted Therapy for Breast Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Targeted Therapy for Breast Cancer Market Size Market Share by Application (2020-2025) 3 Targeted Therapy for Breast Cancer Market Size by Player &nbsp;3.1 Targeted Therapy for Breast Cancer Market Size Market Share by Player &nbsp;3.1.1 Global Targeted Therapy for Breast Cancer Revenue by Player (2020-2025) &nbsp;3.1.2 Global Targeted Therapy for Breast Cancer Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Targeted Therapy for Breast Cancer Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Targeted Therapy for Breast Cancer by Region &nbsp;4.1 Targeted Therapy for Breast Cancer Market Size by Region (2020-2025) &nbsp;4.2 Global Targeted Therapy for Breast Cancer Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Targeted Therapy for Breast Cancer Market Size Growth (2020-2025) &nbsp;4.4 APAC Targeted Therapy for Breast Cancer Market Size Growth (2020-2025) &nbsp;4.5 Europe Targeted Therapy for Breast Cancer Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Targeted Therapy for Breast Cancer Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Targeted Therapy for Breast Cancer Market Size by Country (2020-2025) &nbsp;5.2 Americas Targeted Therapy for Breast Cancer Market Size by Type (2020-2025) &nbsp;5.3 Americas Targeted Therapy for Breast Cancer Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Targeted Therapy for Breast Cancer Market Size by Region (2020-2025) &nbsp;6.2 APAC Targeted Therapy for Breast Cancer Market Size by Type (2020-2025) &nbsp;6.3 APAC Targeted Therapy for Breast Cancer Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Targeted Therapy for Breast Cancer Market Size by Country (2020-2025) &nbsp;7.2 Europe Targeted Therapy for Breast Cancer Market Size by Type (2020-2025) &nbsp;7.3 Europe Targeted Therapy for Breast Cancer Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Targeted Therapy for Breast Cancer by Region (2020-2025) &nbsp;8.2 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Targeted Therapy for Breast Cancer Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Targeted Therapy for Breast Cancer Market Forecast &nbsp;10.1 Global Targeted Therapy for Breast Cancer Forecast by Region (2026-2031) &nbsp;10.1.1 Global Targeted Therapy for Breast Cancer Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Targeted Therapy for Breast Cancer Forecast &nbsp;10.1.3 APAC Targeted Therapy for Breast Cancer Forecast &nbsp;10.1.4 Europe Targeted Therapy for Breast Cancer Forecast &nbsp;10.1.5 Middle East & Africa Targeted Therapy for Breast Cancer Forecast &nbsp;10.2 Americas Targeted Therapy for Breast Cancer Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.2.2 Canada Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.2.3 Mexico Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.2.4 Brazil Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.3 APAC Targeted Therapy for Breast Cancer Forecast by Region (2026-2031) &nbsp;10.3.1 China Targeted Therapy for Breast Cancer Market Forecast &nbsp;10.3.2 Japan Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.3.3 Korea Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.3.4 Southeast Asia Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.3.5 India Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.3.6 Australia Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.4 Europe Targeted Therapy for Breast Cancer Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.4.2 France Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.4.3 UK Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.4.4 Italy Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.4.5 Russia Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.5 Middle East & Africa Targeted Therapy for Breast Cancer Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.5.2 South Africa Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.5.3 Israel Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.5.4 Turkey Market Targeted Therapy for Breast Cancer Forecast &nbsp;10.6 Global Targeted Therapy for Breast Cancer Forecast by Type (2026-2031) &nbsp;10.7 Global Targeted Therapy for Breast Cancer Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Targeted Therapy for Breast Cancer Forecast 11 Key Players Analysis &nbsp;11.1 Eli Lilly and Company &nbsp;11.1.1 Eli Lilly and Company Company Information &nbsp;11.1.2 Eli Lilly and Company Targeted Therapy for Breast Cancer Product Offered &nbsp;11.1.3 Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Eli Lilly and Company Main Business Overview &nbsp;11.1.5 Eli Lilly and Company Latest Developments &nbsp;11.2 Roche &nbsp;11.2.1 Roche Company Information &nbsp;11.2.2 Roche Targeted Therapy for Breast Cancer Product Offered &nbsp;11.2.3 Roche Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Roche Main Business Overview &nbsp;11.2.5 Roche Latest Developments &nbsp;11.3 Merck & Co. &nbsp;11.3.1 Merck & Co. Company Information &nbsp;11.3.2 Merck & Co. Targeted Therapy for Breast Cancer Product Offered &nbsp;11.3.3 Merck & Co. Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Merck & Co. Main Business Overview &nbsp;11.3.5 Merck & Co. Latest Developments &nbsp;11.4 Novartis &nbsp;11.4.1 Novartis Company Information &nbsp;11.4.2 Novartis Targeted Therapy for Breast Cancer Product Offered &nbsp;11.4.3 Novartis Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Novartis Main Business Overview &nbsp;11.4.5 Novartis Latest Developments &nbsp;11.5 Pfizer &nbsp;11.5.1 Pfizer Company Information &nbsp;11.5.2 Pfizer Targeted Therapy for Breast Cancer Product Offered &nbsp;11.5.3 Pfizer Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Pfizer Main Business Overview &nbsp;11.5.5 Pfizer Latest Developments &nbsp;11.6 Merck KGaA &nbsp;11.6.1 Merck KGaA Company Information &nbsp;11.6.2 Merck KGaA Targeted Therapy for Breast Cancer Product Offered &nbsp;11.6.3 Merck KGaA Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Merck KGaA Main Business Overview &nbsp;11.6.5 Merck KGaA Latest Developments &nbsp;11.7 Astellas &nbsp;11.7.1 Astellas Company Information &nbsp;11.7.2 Astellas Targeted Therapy for Breast Cancer Product Offered &nbsp;11.7.3 Astellas Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Astellas Main Business Overview &nbsp;11.7.5 Astellas Latest Developments &nbsp;11.8 Janssen Biotech &nbsp;11.8.1 Janssen Biotech Company Information &nbsp;11.8.2 Janssen Biotech Targeted Therapy for Breast Cancer Product Offered &nbsp;11.8.3 Janssen Biotech Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Janssen Biotech Main Business Overview &nbsp;11.8.5 Janssen Biotech Latest Developments &nbsp;11.9 Bristol-Myers Squibb &nbsp;11.9.1 Bristol-Myers Squibb Company Information &nbsp;11.9.2 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Product Offered &nbsp;11.9.3 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Bristol-Myers Squibb Main Business Overview &nbsp;11.9.5 Bristol-Myers Squibb Latest Developments &nbsp;11.10 Gilead Sciences &nbsp;11.10.1 Gilead Sciences Company Information &nbsp;11.10.2 Gilead Sciences Targeted Therapy for Breast Cancer Product Offered &nbsp;11.10.3 Gilead Sciences Targeted Therapy for Breast Cancer Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Gilead Sciences Main Business Overview &nbsp;11.10.5 Gilead Sciences Latest Developments 12 Research Findings and Conclusion

Report	Global Targeted Therapy for Breast Cancer Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI13704

Buyer Information

Order Summary